海湾与中东 · 综合新闻 · Asharq Al-Awsat
AstraZeneca Says FDA Approves Drug for Rare Kidney Disease in Adults
AstraZeneca said on Wednesday the US Food and Drug Administration granted accelerated approval for its treatment for adults with immunoglobulin A nephropathy, a rare kidney…
在 Asharq Al-Awsat 阅读全文 登录后可收藏MarketNews 仅展示媒体发布的标题和摘要，全文请在出版方网站阅读。 (english.aawsat.com)
